Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Days Sales Outstanding : 116.43 (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Hainan Huluwa Pharmaceutical Group Co Days Sales Outstanding?

Hainan Huluwa Pharmaceutical Group Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥549 Mil. Hainan Huluwa Pharmaceutical Group Co's Revenue for the three months ended in Mar. 2024 was ¥430 Mil. Hence, Hainan Huluwa Pharmaceutical Group Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 116.43.

The historical rank and industry rank for Hainan Huluwa Pharmaceutical Group Co's Days Sales Outstanding or its related term are showing as below:

SHSE:605199' s Days Sales Outstanding Range Over the Past 10 Years
Min: 19.94 Med: 49.92 Max: 95.87
Current: 95.87

During the past 8 years, Hainan Huluwa Pharmaceutical Group Co's highest Days Sales Outstanding was 95.87. The lowest was 19.94. And the median was 49.92.

SHSE:605199's Days Sales Outstanding is ranked worse than
71.64% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.84 vs SHSE:605199: 95.87

Hainan Huluwa Pharmaceutical Group Co's Days Sales Outstanding increased from Mar. 2023 (61.02) to Mar. 2024 (116.43).

Hainan Huluwa Pharmaceutical Group Co Days Sales Outstanding Historical Data

The historical data trend for Hainan Huluwa Pharmaceutical Group Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Huluwa Pharmaceutical Group Co Days Sales Outstanding Chart

Hainan Huluwa Pharmaceutical Group Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

34.12

65.72

82.28

78.61

81.72

Hainan Huluwa Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															61.02	94.65	110.78	73.82	116.43

Competitive Comparison of Hainan Huluwa Pharmaceutical Group Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Hainan Huluwa Pharmaceutical Group Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hainan Huluwa Pharmaceutical Group Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hainan Huluwa Pharmaceutical Group Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Hainan Huluwa Pharmaceutical Group Co's Days Sales Outstanding falls into.

Hainan Huluwa Pharmaceutical Group Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Hainan Huluwa Pharmaceutical Group Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (312.493	+	540.601)	/	2 )	/	1905.182	*	365
=	426.547					/	1905.182	*	365
=	81.72

Hainan Huluwa Pharmaceutical Group Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (540.601	+	557.741)	/	2 )	/	430.405	*	365 / 4
=	549.171					/	430.405	*	365 / 4
=	116.43

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Hainan Huluwa Pharmaceutical Group Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Hainan Huluwa Pharmaceutical Group Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Huluwa Pharmaceutical Group Co Ltd (SHSE:605199) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

No. 8, Yaogu 4th Road, Phase II, Yaogu Industrial Park, Haikou National High-tech Zone, Hainan Province, Haikou, CHN, 570300

Website

http://www.huluwayaoye.com

Hainan Huluwa Pharmaceutical Group Co Ltd is engaged in production and sales of Chinese patent medicines and chemical drugs. The company produces medicines for children's respiratory and digestive systems. Its products include star products, calabash, gourd dad, and gourd mom.

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Headlines

No Headlines